RT Journal Article SR Electronic T1 Interleukin-17A Mediates Resistance to Anti-VEGF Therapy JF Cancer Discovery JO CANCER DISCOVERY FD American Association for Cancer Research SP OF16 OP OF16 DO 10.1158/2159-8290.CD-RW2013-176 VO 3 IS 10 YR 2013 UL http://cancerdiscovery.aacrjournals.org/content/3/10/OF16.abstract AB Interleukin (IL)-17-secreting TH17 cells reduce sensitivity to VEGF-specific antibodies.